Product Description
The drug belongs to the class of drugs called proteasome inhibitors. Being a remarkable organization, we bring forth a striking assortment of Velcade Injection. Doctors use it to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma. We source this drug from the most reliable vendors of the market. Velcade Injection prevents proteasomes proteins which play an important role in growth and multiplication of cancer cells. We offer this drug at reasonable prices to clients.
Features:
- Reduces blood supply to tumor
- Blocks cancer growth
- Extended shelf life
Key Therapeutic IndicationsVelcade Injection is primarily indicated for patients diagnosed with multiple myeloma and mantle cell lymphoma. The product acts as a proteasome inhibitor, disrupting cellular processes crucial for cancer cell survival and proliferation, thus supporting effective cancer therapy.
Reconstitution and Administration ProcessThis injectable must be reconstituted using 0.9% Sodium Chloride Injection before administration. It can then be delivered either intravenously or subcutaneously. Detailed procedures ensure correct usage, maximize efficacy, and preserve stability after preparation. Utilize within 8 hours at room temperature as per guidelines.
Safety, Storage, and HandlingVelcade should be stored below 25C and away from direct light exposure to preserve its stability and effectiveness. The single-use vials are odorless, lyophilized, and designed for ease of use. Appropriate storage and handling minimize the risk of degradation and ensure patient safety.
FAQs of Velcade Injection:
Q: How should Velcade Injection be prepared for administration?
A: Velcade Injection should be reconstituted using 0.9% Sodium Chloride Injection. Use aseptic technique to mix the powder in the vial as prescribed. Once reconstituted, the solution should be administered within 8 hours if kept at room temperature.
Q: What conditions is Velcade Injection prescribed to treat?
A: Velcade Injection is indicated for the treatment of multiple myeloma and mantle cell lymphoma. It works as a proteasome inhibitor, slowing cancer cell growth and improving disease management in these conditions.
Q: When should Velcade Injection not be used?
A: This medication is contraindicated in patients with hypersensitivity to Bortezomib, boron, or any other components of the formulation. Please consult your healthcare provider for a full list of contraindications and precautions.
Q: Where should Velcade Injection vials be stored before use?
A: Store unopened vials of Velcade below 25C and protect them from light. Following these storage guidelines will help maintain the products stability and shelf life for up to 24 months.
Q: What are the benefits of using Velcade Injection?
A: Velcade offers targeted anticancer therapy by inhibiting 26S proteasome activity in malignant cells. This action disrupts cancer cell survival mechanisms, making Velcade an effective option for patients with specific types of blood cancers.
Q: Is Velcade Injection suitable for at-home use?
A: Velcade is a prescription-only medication and should be administered by trained healthcare professionals in a clinical setting to ensure proper dosing and monitoring for any adverse effects.